Genes Identified That Increase Children's Risk Of Blood Infection
By LabMedica International staff writers Posted on 16 Jun 2016 |
Image: The MassARRAY system for iPlex single nucleotide polymorphism (SNP) genotyping (Photo courtesy of Sequenom).
Bacteremia is a bacterial infection of the bloodstream, and a major cause of illness and death in sub-Saharan Africa but little is known about whether human genetics play a part.
The leading bacterial cause of death in young children worldwide is Streptococcus pneumoniae or pneumococcus and 14.5 million episodes of serious pneumococcal disease occur in young children annually. Genes have been identified that make certain children more susceptible to invasive bacterial infections.
A global network of scientists coordinated from the Wellcome Trust Centre for Human Genetics (Oxford, UK), carried out a genome-wide association study to identify which genes might be associated with an increased likelihood of developing bacteremia. The study looked at DNA samples from more than 4,500 Kenyan children from the Kilifi area where there is a high occurrence of bacteremia. Just over 4,000 children were healthy, while slightly more than 500 had pneumococcal bacteremia.
Genomic DNA was extracted using the QIAamp DNA blood mini kit (QIAGEN, Hilden, Germany) and whole-genome amplified samples from case and control subjects were genotyped on the genome-wide Affymetrix SNP 6.0 chip (Affymetrix Inc, Santa Clara, CA, USA). Single nucleotide polymorphisms (SNP) in the additive or the genotypic model were directly genotyped in the discovery set to confirm imputation accuracy and in the replication sample set to confirm the associations using two iPLEX assays (Sequenom, San Diego, CA, USA). To quantify levels of long intergenic non-coding ribonucleic acid (RNA) expression, the teams performed quantitative real-time polymerase chain reaction (qPCR) using a relative quantification method.
The study found an area of two long intergenic noncoding RNA (lincRNA) genes that was associated with susceptibility to pneumococcal bacteremia. LincRNAs are RNA transcripts that are longer than 200 nucleotides but are not translated into proteins. LincRNAs are still little understood, although it is believed that the human genome has more than 10,000 of them.
Anna Rautanen, PhD, a senior author of the study, said, “'One of the associated lincRNA genes, called AC011288.2, is expressed only in neutrophils, cells that are known to have a key role in clearing pneumococcal disease. Critically, the genetic variants we have identified carry a doubled risk of developing bacteremia when infected with the Streptococcus pneumoniae bacteria. This discovery therefore provides clues in the pressing search for new ways to target the disease.” The study was published on June 2, 2016, in the American Journal of Human Genetics.
Related Links:
Wellcome Trust Centre for Human Genetics
QIAGEN
Affymetrix
Sequenom
The leading bacterial cause of death in young children worldwide is Streptococcus pneumoniae or pneumococcus and 14.5 million episodes of serious pneumococcal disease occur in young children annually. Genes have been identified that make certain children more susceptible to invasive bacterial infections.
A global network of scientists coordinated from the Wellcome Trust Centre for Human Genetics (Oxford, UK), carried out a genome-wide association study to identify which genes might be associated with an increased likelihood of developing bacteremia. The study looked at DNA samples from more than 4,500 Kenyan children from the Kilifi area where there is a high occurrence of bacteremia. Just over 4,000 children were healthy, while slightly more than 500 had pneumococcal bacteremia.
Genomic DNA was extracted using the QIAamp DNA blood mini kit (QIAGEN, Hilden, Germany) and whole-genome amplified samples from case and control subjects were genotyped on the genome-wide Affymetrix SNP 6.0 chip (Affymetrix Inc, Santa Clara, CA, USA). Single nucleotide polymorphisms (SNP) in the additive or the genotypic model were directly genotyped in the discovery set to confirm imputation accuracy and in the replication sample set to confirm the associations using two iPLEX assays (Sequenom, San Diego, CA, USA). To quantify levels of long intergenic non-coding ribonucleic acid (RNA) expression, the teams performed quantitative real-time polymerase chain reaction (qPCR) using a relative quantification method.
The study found an area of two long intergenic noncoding RNA (lincRNA) genes that was associated with susceptibility to pneumococcal bacteremia. LincRNAs are RNA transcripts that are longer than 200 nucleotides but are not translated into proteins. LincRNAs are still little understood, although it is believed that the human genome has more than 10,000 of them.
Anna Rautanen, PhD, a senior author of the study, said, “'One of the associated lincRNA genes, called AC011288.2, is expressed only in neutrophils, cells that are known to have a key role in clearing pneumococcal disease. Critically, the genetic variants we have identified carry a doubled risk of developing bacteremia when infected with the Streptococcus pneumoniae bacteria. This discovery therefore provides clues in the pressing search for new ways to target the disease.” The study was published on June 2, 2016, in the American Journal of Human Genetics.
Related Links:
Wellcome Trust Centre for Human Genetics
QIAGEN
Affymetrix
Sequenom
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia